Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dexlansoprazole for Injection

Approval Number

国药准字H20240001

Company江苏奥赛康药业有限公司

Registration Date

January 9, 2024

Drug Information

Generic Name

注射用右兰索拉唑

Dosage Form

注射剂

Strength

15mg

Drug Type

化学药品

Registration Date

January 9, 2024

Company Information

Applicant Company

Company Name江苏奥赛康药业有限公司

Company Address

南京江宁科学园科建路699号

Manufacturing Company

Company Name江苏奥赛康药业有限公司

Company Address

南京江宁科学园科建路699号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy